Correlation Between Neurobiological Technologies and OKYO Pharma

Can any of the company-specific risk be diversified away by investing in both Neurobiological Technologies and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobiological Technologies and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurobiological Technologies and OKYO Pharma Ltd, you can compare the effects of market volatilities on Neurobiological Technologies and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobiological Technologies with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobiological Technologies and OKYO Pharma.

Diversification Opportunities for Neurobiological Technologies and OKYO Pharma

0.0

Correlation Coefficient

Neurobiological Technologies  OKYO Pharma

Pay attention - limited upside

The 3 months correlation between Neurobiological and OKYO is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neurobiological Technologies and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Neurobiological Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobiological Technologies are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Neurobiological Technologies i.e., Neurobiological Technologies and OKYO Pharma go up and down completely randomly.

Pair Corralation between Neurobiological Technologies and OKYO Pharma

If you would invest  226.00  in OKYO Pharma Ltd on October 12, 2024 and sell it today you would lose (97.00) from holding OKYO Pharma Ltd or give up 42.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	23.64%
Values	Daily Returns

Neurobiological Technologies  vs.  OKYO Pharma Ltd

Neurobiological Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

OKYO Pharma

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in OKYO Pharma Ltd are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, OKYO Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurobiological Technologies and OKYO Pharma

The main advantage of trading using opposite Neurobiological Technologies and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobiological Technologies position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.

The idea behind Neurobiological Technologies and OKYO Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.